speb/financial-data huggingface dataset:
DBCORP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -49480000.00
DBCORP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -49480000.00
DBCORP.NS income_statement (quarterly, 2025-12-31) — Write Off: 49480000.00
DBCORP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 12952270000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 3300710000.00
DBCORP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 23555210000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 5763910000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1840420000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1840420000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4640980000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4640980000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 3166360000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3166360000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 178206656.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 178200573.00
DBCORP.NS income_statement (annual, 2026-03-31) — Basic EPS: 18.63
DBCORP.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.49
DBCORP.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1218830000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1722350000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 2412100000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2412100000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1782460000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1782460000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1062320000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1062320000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9714580000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9714580000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -1247830000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 381590000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 215840000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -44150000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Payable: -583420000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -330440000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -271980000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -156520000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1782460000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1782460000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 24288060000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 24288060000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 730000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 27600000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 27600000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 6506610000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1628050000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 17076320000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 17076320000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 390100000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 390100000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Current Debt: 210040000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 210040000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 600140000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 600140000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4312130000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4312130000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Depreciation: 998310000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 998310000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 998310000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 255460000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 998310000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 255460000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 178302363.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 178200573.00
DBCORP.NS income_statement (annual, 2026-03-31) — Diluted EPS: 18.62
DBCORP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.49
DBCORP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 621920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — EBIT: 4737780000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — EBIT: 920290000.00
DBCORP.NS income_statement (annual, 2026-03-31) — EBITDA: 5736090000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1175750000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1062320000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -2082170000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1929730000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 15190000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 12880000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Goodwill: 19130000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 19130000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 562600000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 562600000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 9954900000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 9954900000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Gross Profit: 17048600000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 4135860000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Interest Expense: 259660000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 68240000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 259660000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 68240000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -259790000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 1264320000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Inventory: 2154550000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2154550000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 24498100000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 24498100000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1726430000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 549010000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 549010000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 3166360000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 3166360000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 730000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 794130000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 2022000000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2022000000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2022000000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2022000000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 730000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 8190000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income: 621920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 621920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 621920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 621920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 621920000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 4478120000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 3319990000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 621920000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -158010000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Interest Income: -259660000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -68240000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Investment Properties Purchase And Sale: 87700000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1250710000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -376230000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -259660000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -68240000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -10000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 9954900000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 9954900000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1556260000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -376230000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 23725460000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 23725460000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 35720000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 35720000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 326060000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 326060000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 589920000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 589920000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 5947450000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1222380000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Normalized Income: 3476688142.61
DBCORP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 655955713.40
DBCORP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 3652080000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Operating Income: 4096330000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Operating Income: 835150000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 23555210000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 5763910000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 178245926.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 178245926.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 10000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 566210000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 566210000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 316360000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 316360000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 22505600000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 22505600000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 543470000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 543470000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -509390000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 112030000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 112030000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1500000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1500000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 852810000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 131770000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 7357400000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1887490000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Properties: 9927300000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 9927300000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 8652260000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 8652260000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Payables: 1905230000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1905230000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 301680000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 301680000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Pretax Income: 4478120000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 852050000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -1570000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -158010000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -10197010000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1564340000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 6506610000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1628050000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 998310000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 255460000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1170360000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 8946300000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Sale Of Investment Properties: 87700000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 8080000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 178245926.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 178245926.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 794130000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -1170360000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Special Income Charges: -211360000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -46630000.00
DBCORP.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 980000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 24288060000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 24288060000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 23725460000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 23725460000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -54661857.39
DBCORP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -12594286.60
DBCORP.NS income_statement (annual, 2026-03-31) — Tax Provision: 1158130000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 230130000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
DBCORP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
DBCORP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1275710000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 31965840000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 31965840000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 24288060000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 24288060000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2622140000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2622140000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 24288060000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 24288060000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Total Expenses: 19458880000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4928760000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 7677780000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7677780000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 14889520000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 14889520000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3365650000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3365650000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 64810000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 64810000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -211360000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -46630000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -211360000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -46630000.00
DBCORP.NS balance_sheet (annual, 2026-03-31) — Working Capital: 12764190000.00
DBCORP.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 12764190000.00
DBCORP.NS income_statement (annual, 2026-03-31) — Write Off: 211360000.00
DBCORP.NS income_statement (quarterly, 2026-03-31) — Write Off: 46630000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 3136110000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 6037390000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 178274336.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 5.65
DBCORP.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 1781170000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 244150000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 244150000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 178274336.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 5.65
DBCORP.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — EBIT: 1403110000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — EBITDA: 1647260000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 4256220000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 61020000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 61020000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Minority Interests: 0.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -61020000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -61020000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 1647260000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 1007250000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Operating Income: 1120110000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 6037390000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 283000000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 1745190000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 1342090000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 1781170000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 244150000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 334840000.00
DBCORP.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
DBCORP.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 4917280000.00
DBD income_statement (annual, 2021-12-31) — +Operating Expense: 901900000.00
DBD income_statement (annual, 2021-12-31) — +Total Revenue: 3905200000.00
DBD cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 78200000.00
DBD cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 78200000.00
DBD cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 1300000.00
DBD balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 73400000.00
DBD income_statement (annual, 2021-12-31) — Basic EPS: -1.01
DBD cash_flow (annual, 2021-12-31) — Beginning Cash Position: 324500000.00
DBD cash_flow (annual, 2021-12-31) — Capital Expenditure: -51300000.00
DBD cash_flow (annual, 2021-12-31) — Capital Expenditure Reported: -51300000.00
DBD balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 157500000.00
DBD cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: -3600000.00
DBD cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -49200000.00
DBD cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: 123300000.00
DBD cash_flow (annual, 2021-12-31) — Change In Account Payable: 241400000.00
DBD cash_flow (annual, 2021-12-31) — Change In Accrued Expense: -43100000.00
DBD cash_flow (annual, 2021-12-31) — Change In Inventory: -84800000.00
DBD cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 300000.00
DBD cash_flow (annual, 2021-12-31) — Change In Other Working Capital: -100800000.00
DBD cash_flow (annual, 2021-12-31) — Change In Payable: 241400000.00
DBD cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 198300000.00
DBD cash_flow (annual, 2021-12-31) — Change In Receivables: 16400000.00
DBD cash_flow (annual, 2021-12-31) — Change In Working Capital: 29400000.00
DBD cash_flow (annual, 2021-12-31) — Changes In Account Receivables: 16400000.00
DBD cash_flow (annual, 2021-12-31) — Changes In Cash: 70500000.00
DBD income_statement (annual, 2021-12-31) — Cost Of Revenue: 2861800000.00
DBD balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 54500000.00
DBD balance_sheet (annual, 2021-12-31) — Current Debt: 47100000.00
DBD balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 101600000.00
DBD cash_flow (annual, 2021-12-31) — Deferred Income Tax: -12600000.00
DBD cash_flow (annual, 2021-12-31) — Deferred Tax: -12600000.00
DBD cash_flow (annual, 2021-12-31) — Depreciation: 70900000.00
DBD cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 149100000.00
DBD cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 149100000.00
DBD income_statement (annual, 2021-12-31) — Diluted EPS: -1.01
DBD income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -78800000.00
DBD income_statement (annual, 2021-12-31) — EBIT: 144600000.00
DBD income_statement (annual, 2021-12-31) — EBITDA: 293700000.00
DBD income_statement (annual, 2021-12-31) — Earnings From Equity Interest Net Of Tax: 300000.00
DBD cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: -5700000.00
DBD cash_flow (annual, 2021-12-31) — End Cash Position: 388900000.00
DBD cash_flow (annual, 2021-12-31) — Financing Cash Flow: -3600000.00
DBD cash_flow (annual, 2021-12-31) — Free Cash Flow: 72000000.00
DBD income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: -3100000.00
DBD income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -2000000.00
DBD income_statement (annual, 2021-12-31) — Gross Profit: 1043400000.00
DBD income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 1300000.00
DBD cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 42300000.00
DBD income_statement (annual, 2021-12-31) — Interest Expense: 195300000.00
DBD income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 195300000.00
DBD income_statement (annual, 2021-12-31) — Interest Income: 6100000.00
DBD income_statement (annual, 2021-12-31) — Interest Income Non Operating: 6100000.00
DBD cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 175100000.00
DBD cash_flow (annual, 2021-12-31) — Investing Cash Flow: -49200000.00
DBD balance_sheet (annual, 2021-12-31) — Investments And Advances: 11000000.00
DBD cash_flow (annual, 2021-12-31) — Issuance Of Debt: 12100000.00
DBD balance_sheet (annual, 2021-12-31) — Line Of Credit: 1600000.00
DBD balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 103000000.00
DBD cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 12100000.00
DBD cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -19400000.00
DBD income_statement (annual, 2021-12-31) — Minority Interests: -700000.00
DBD cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 1100000.00
DBD income_statement (annual, 2021-12-31) — Net Income: -78800000.00
DBD income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -78800000.00
DBD income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -78100000.00
DBD income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -78800000.00
DBD income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -78800000.00
DBD cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -78100000.00
DBD income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -78100000.00
DBD income_statement (annual, 2021-12-31) — Net Interest Income: -189200000.00
DBD cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -700000.00
DBD cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -7300000.00
DBD cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -7300000.00
DBD income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -189200000.00
DBD cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 3700000.00
DBD cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 1700000.00
DBD income_statement (annual, 2021-12-31) — Normalized EBITDA: 300100000.00
DBD income_statement (annual, 2021-12-31) — Normalized Income: -74128000.00
DBD cash_flow (annual, 2021-12-31) — Operating Cash Flow: 123300000.00
DBD cash_flow (annual, 2021-12-31) — Operating Gains Losses: 3100000.00
DBD income_statement (annual, 2021-12-31) — Operating Income: 141500000.00
DBD income_statement (annual, 2021-12-31) — Operating Revenue: 3905200000.00
DBD cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: -400000.00
DBD balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 47100000.00
DBD income_statement (annual, 2021-12-31) — Other Income Expense: -3000000.00
DBD cash_flow (annual, 2021-12-31) — Other Non Cash Items: 17300000.00
DBD income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 3400000.00
DBD cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 0.00
DBD balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 186500000.00
DBD balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
DBD income_statement (annual, 2021-12-31) — Pretax Income: -50700000.00
DBD cash_flow (annual, 2021-12-31) — Purchase Of Investment: -288400000.00
DBD income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 2861800000.00
DBD income_statement (annual, 2021-12-31) — Reconciled Depreciation: 149100000.00
DBD cash_flow (annual, 2021-12-31) — Repayment Of Debt: -19400000.00
DBD income_statement (annual, 2021-12-31) — Research And Development: 126300000.00
DBD income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
DBD cash_flow (annual, 2021-12-31) — Sale Of Business: 1100000.00
DBD cash_flow (annual, 2021-12-31) — Sale Of Investment: 287700000.00
DBD income_statement (annual, 2021-12-31) — Selling General And Administration: 775600000.00
DBD income_statement (annual, 2021-12-31) — Special Income Charges: -4400000.00
DBD cash_flow (annual, 2021-12-31) — Stock Based Compensation: 13800000.00
DBD income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: -1728000.00
DBD income_statement (annual, 2021-12-31) — Tax Provision: 27700000.00
DBD income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.27
DBD income_statement (annual, 2021-12-31) — Total Expenses: 3763700000.00
DBD income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 137100000.00
DBD income_statement (annual, 2021-12-31) — Total Unusual Items: -6400000.00
DBD income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -6400000.00
DBD balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 16247409.00
DBD income_statement (annual, 2021-12-31) — Write Off: 1300000.00
DBD income_statement (annual, 2022-12-31) — +Operating Expense: 862300000.00
DBD income_statement (annual, 2022-12-31) — +Total Revenue: 3460700000.00
DBD balance_sheet (annual, 2022-12-31) — Accounts Payable: 611600000.00
DBD balance_sheet (annual, 2022-12-31) — Accounts Receivable: 612200000.00
DBD balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -479400000.00
DBD balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 831500000.00
DBD balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -34500000.00
DBD cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 69600000.00
DBD cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 69600000.00
DBD cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 111800000.00
DBD balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 7900000.00
DBD income_statement (annual, 2022-12-31) — Basic Average Shares: 79000000.00
DBD income_statement (annual, 2022-12-31) — Basic EPS: -7.36
DBD cash_flow (annual, 2022-12-31) — Beginning Cash Position: 388900000.00
DBD balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 68300000.00
DBD cash_flow (annual, 2022-12-31) — Capital Expenditure: -53100000.00
DBD cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -53100000.00
DBD balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 115700000.00
DBD balance_sheet (annual, 2022-12-31) — Capital Stock: 119800000.00
DBD balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 307400000.00
DBD balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 332000000.00
DBD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 349800000.00
DBD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -23800000.00
DBD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -387900000.00
DBD cash_flow (annual, 2022-12-31) — Change In Account Payable: -66500000.00
DBD cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -115600000.00
DBD cash_flow (annual, 2022-12-31) — Change In Inventory: -74500000.00
DBD cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -7300000.00
DBD cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 147200000.00
DBD cash_flow (annual, 2022-12-31) — Change In Payable: -66500000.00
DBD cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -182100000.00
DBD cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3900000.00
DBD cash_flow (annual, 2022-12-31) — Change In Receivables: -49400000.00
DBD cash_flow (annual, 2022-12-31) — Change In Working Capital: -170000000.00
DBD cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -49400000.00
DBD cash_flow (annual, 2022-12-31) — Changes In Cash: -61900000.00
DBD balance_sheet (annual, 2022-12-31) — Common Stock: 119800000.00
DBD balance_sheet (annual, 2022-12-31) — Common Stock Equity: -1380900000.00
DBD balance_sheet (annual, 2022-12-31) — Construction In Progress: 4600000.00
DBD income_statement (annual, 2022-12-31) — Cost Of Revenue: 2703400000.00
DBD balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 107900000.00
DBD balance_sheet (annual, 2022-12-31) — Current Assets: 1770900000.00
DBD balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 39000000.00
DBD balance_sheet (annual, 2022-12-31) — Current Debt: 24000000.00
DBD balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 63000000.00
DBD balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 453200000.00
DBD balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 453200000.00
DBD balance_sheet (annual, 2022-12-31) — Current Liabilities: 1604900000.00
DBD cash_flow (annual, 2022-12-31) — Deferred Income Tax: 92900000.00
DBD cash_flow (annual, 2022-12-31) — Deferred Tax: 92900000.00
DBD cash_flow (annual, 2022-12-31) — Depreciation: 56400000.00
DBD cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 126000000.00
DBD cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 126000000.00
DBD income_statement (annual, 2022-12-31) — Diluted Average Shares: 79000000.00
DBD income_statement (annual, 2022-12-31) — Diluted EPS: -7.36
DBD income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -581400000.00
DBD income_statement (annual, 2022-12-31) — EBIT: -239400000.00
DBD income_statement (annual, 2022-12-31) — EBITDA: -113400000.00
DBD income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 2200000.00
DBD cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -8200000.00
DBD balance_sheet (annual, 2022-12-31) — Employee Benefits: 40600000.00
DBD cash_flow (annual, 2022-12-31) — End Cash Position: 319100000.00
DBD cash_flow (annual, 2022-12-31) — Financing Cash Flow: 349800000.00
DBD balance_sheet (annual, 2022-12-31) — Finished Goods: 229400000.00
DBD cash_flow (annual, 2022-12-31) — Free Cash Flow: -441000000.00
DBD income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 5100000.00
DBD income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -7800000.00
DBD balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -360000000.00
DBD balance_sheet (annual, 2022-12-31) — Goodwill: 702300000.00
DBD balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 959900000.00
DBD balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 646700000.00
DBD balance_sheet (annual, 2022-12-31) — Gross PPE: 708500000.00
DBD income_statement (annual, 2022-12-31) — Gross Profit: 757300000.00
DBD income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 111800000.00
DBD cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 33100000.00
DBD income_statement (annual, 2022-12-31) — Interest Expense: 199200000.00
DBD income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 199200000.00
DBD income_statement (annual, 2022-12-31) — Interest Income: 10000000.00
DBD income_statement (annual, 2022-12-31) — Interest Income Non Operating: 10000000.00
DBD cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 231600000.00
DBD balance_sheet (annual, 2022-12-31) — Inventory: 588100000.00
DBD balance_sheet (annual, 2022-12-31) — Invested Capital: 1228900000.00
DBD cash_flow (annual, 2022-12-31) — Investing Cash Flow: -23800000.00
DBD balance_sheet (annual, 2022-12-31) — Investments And Advances: 7600000.00
DBD cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1080000000.00
DBD balance_sheet (annual, 2022-12-31) — Land And Improvements: 10000000.00
DBD balance_sheet (annual, 2022-12-31) — Leases: 17100000.00
DBD balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 76700000.00
DBD balance_sheet (annual, 2022-12-31) — Long Term Debt: 2585800000.00
DBD balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2662500000.00
DBD cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1080000000.00
DBD cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -703900000.00
DBD balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 365300000.00
DBD balance_sheet (annual, 2022-12-31) — Minority Interest: 9800000.00
DBD income_statement (annual, 2022-12-31) — Minority Interests: 4200000.00
DBD cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 10500000.00
DBD balance_sheet (annual, 2022-12-31) — Net Debt: 2302400000.00
DBD income_statement (annual, 2022-12-31) — Net Income: -581400000.00
DBD income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -581400000.00
DBD income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -585600000.00
DBD income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -581400000.00
DBD income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -581400000.00
DBD cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -585600000.00
DBD income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -585600000.00
DBD income_statement (annual, 2022-12-31) — Net Interest Income: -221300000.00
DBD cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 12800000.00
DBD cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 376100000.00
DBD cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 376100000.00
DBD income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -221300000.00
DBD cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -26300000.00
DBD cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 6000000.00
DBD balance_sheet (annual, 2022-12-31) — Net PPE: 229100000.00
DBD balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -2340800000.00
DBD balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 0.00
DBD balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 96600000.00
DBD balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 0.00
DBD balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 96600000.00
DBD balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 40600000.00
DBD income_statement (annual, 2022-12-31) — Normalized EBITDA: 1100000.00
DBD income_statement (annual, 2022-12-31) — Normalized Income: -490945000.00
DBD cash_flow (annual, 2022-12-31) — Operating Cash Flow: -387900000.00
DBD cash_flow (annual, 2022-12-31) — Operating Gains Losses: 5000000.00
DBD income_statement (annual, 2022-12-31) — Operating Income: -105000000.00
DBD income_statement (annual, 2022-12-31) — Operating Revenue: 3460700000.00
DBD balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 79103450.00
DBD cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 300000.00
DBD balance_sheet (annual, 2022-12-31) — Other Current Assets: 168500000.00
DBD balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 24000000.00
DBD balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 369200000.00
DBD balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -360000000.00
DBD balance_sheet (annual, 2022-12-31) — Other Equity Interest: 20100000.00
DBD income_statement (annual, 2022-12-31) — Other Income Expense: -112300000.00
DBD balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 257600000.00
DBD cash_flow (annual, 2022-12-31) — Other Non Cash Items: 18600000.00
DBD balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 97400000.00
DBD balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 31500000.00
DBD income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2200000.00
DBD balance_sheet (annual, 2022-12-31) — Other Properties: 243200000.00
DBD balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 24600000.00
DBD balance_sheet (annual, 2022-12-31) — Payables: 611600000.00
DBD balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 719500000.00
DBD cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 10100000.00
DBD balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
DBD balance_sheet (annual, 2022-12-31) — Prepaid Assets: 50500000.00
DBD income_statement (annual, 2022-12-31) — Pretax Income: -438600000.00
DBD balance_sheet (annual, 2022-12-31) — Properties: 0.00
DBD cash_flow (annual, 2022-12-31) — Purchase Of Investment: -401300000.00
DBD balance_sheet (annual, 2022-12-31) — Raw Materials: 358700000.00
DBD balance_sheet (annual, 2022-12-31) — Receivables: 612200000.00
DBD income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2703400000.00
DBD income_statement (annual, 2022-12-31) — Reconciled Depreciation: 126000000.00
DBD cash_flow (annual, 2022-12-31) — Repayment Of Debt: -703900000.00
DBD income_statement (annual, 2022-12-31) — Research And Development: 120700000.00
DBD balance_sheet (annual, 2022-12-31) — Restricted Cash: 11700000.00
DBD income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
DBD balance_sheet (annual, 2022-12-31) — Retained Earnings: -1406700000.00
DBD cash_flow (annual, 2022-12-31) — Sale Of Business: 10500000.00
DBD cash_flow (annual, 2022-12-31) — Sale Of Investment: 414100000.00
DBD income_statement (annual, 2022-12-31) — Selling General And Administration: 741600000.00
DBD balance_sheet (annual, 2022-12-31) — Share Issued: 95779719.00
DBD income_statement (annual, 2022-12-31) — Special Income Charges: -106700000.00
DBD cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13400000.00
DBD balance_sheet (annual, 2022-12-31) — Stockholders Equity: -1380900000.00
DBD balance_sheet (annual, 2022-12-31) — Tangible Book Value: -2340800000.00
DBD income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -24045000.00
DBD income_statement (annual, 2022-12-31) — Tax Provision: 149200000.00
DBD income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
DBD balance_sheet (annual, 2022-12-31) — Total Assets: 3065000000.00
DBD balance_sheet (annual, 2022-12-31) — Total Capitalization: 1204900000.00
DBD balance_sheet (annual, 2022-12-31) — Total Debt: 2725500000.00
DBD balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -1371100000.00
DBD income_statement (annual, 2022-12-31) — Total Expenses: 3565700000.00
DBD balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4436100000.00
DBD balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1294000000.00
DBD balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2831200000.00
DBD income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -211700000.00
DBD income_statement (annual, 2022-12-31) — Total Other Finance Cost: 32100000.00
DBD income_statement (annual, 2022-12-31) — Total Unusual Items: -114500000.00
DBD income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -114500000.00
DBD balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 16676269.00
DBD balance_sheet (annual, 2022-12-31) — Treasury Stock: 585600000.00
DBD balance_sheet (annual, 2022-12-31) — Working Capital: 166000000.00
DBD income_statement (annual, 2022-12-31) — Write Off: 106700000.00
DBD balance_sheet (annual, 2023-12-31) — Accounts Payable: 529000000.00
DBD balance_sheet (annual, 2023-12-31) — Accounts Receivable: 721800000.00
DBD balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -14300000.00
DBD balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1038700000.00
DBD balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3600000.00
DBD balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
DBD income_statement (annual, 2023-12-31) — Basic Average Shares: 37566678.00
DBD balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 48000000.00
DBD balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 104700000.00
DBD balance_sheet (annual, 2023-12-31) — Capital Stock: 400000.00
DBD balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 550200000.00
DBD balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 563600000.00
DBD balance_sheet (annual, 2023-12-31) — Common Stock: 400000.00
DBD balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1063800000.00
DBD balance_sheet (annual, 2023-12-31) — Construction In Progress: 9400000.00
DBD balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 160100000.00
DBD balance_sheet (annual, 2023-12-31) — Current Assets: 2153900000.00
DBD balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 39600000.00